Drug‐induced proarrhythmic effects: assessment of changes in QT interval
- 1 October 2000
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 50 (4) , 297-302
- https://doi.org/10.1046/j.1365-2125.2000.00274.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarizationThe American Journal of Cardiology, 1999
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarctionInternational Journal of Cardiology, 1998
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variabilityAmerican Heart Journal, 1996
- Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusionCardiovascular Research, 1994
- Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycinClinical Pharmacology & Therapeutics, 1992
- A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandActa Psychiatrica Scandinavica, 1991
- Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts.Circulation Research, 1988
- Diseases and drugs causing prolongation of the QT intervalThe American Journal of Cardiology, 1987
- Flecainide: Electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardiaThe American Journal of Cardiology, 1985